TLDR Satoyoshi syndrome can cause eye problems like uveitis and retinal vein issues.
A 32-year-old woman with Satoyoshi syndrome experienced sudden visual disturbances and was diagnosed with granulomatous pan-uveitis and impending central retinal vein occlusion (CRVO). Treatment with increased doses of prednisolone, oral aspirin, and kallidinogenase improved her retinal condition and visual acuity. However, she later developed uncontrollable intraocular pressure (IOP), necessitating surgical interventions. This case suggests a potential link between Satoyoshi syndrome and uveitis, but more cases are needed to clarify this relationship.
8 citations,
June 2019 in “Orphanet journal of rare diseases” Corticosteroids are the most effective treatment for Satoyoshi syndrome.
[object Object]
8 citations,
June 2019 in “Orphanet journal of rare diseases” Corticosteroids are the most effective treatment for Satoyoshi syndrome.
18 citations,
February 2006 in “Brain & development” A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.
[object Object] 
March 2014 in “Journal of The American Academy of Dermatology” The document lists various dermatology topics, treatments, and diagnostic methods.
July 2022 in “medRxiv (Cold Spring Harbor Laboratory)” Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.
13 citations,
October 2003 in “Clinical pediatrics” Steroid treatment greatly improved the symptoms of a boy with a rare disorder called Satoyoshi syndrome.
